MPS Pharmaa Ltd Financials

MPS Pharmaa Ltd Financial Statement

MPS Pharmaa Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	TBA	TBA	TBA
Operating Expense	0.19	0.20	0.21
Net Profit	-0.22	-0.22	-0.24
Net Profit Margin	TBA	TBA	TBA
Earning Per Share	-0.12	-0.12	-0.13
EBIDTA	-0.18	-0.18	-0.20
Effective Tax Rate	TBA	TBA	TBA

Particulars	Sep 2024
Revenue	TBA
Operating Expense	0.19
Net Profit	-0.22
Net Profit Margin	TBA
Earning Per Share	-0.12
EBIDTA	-0.18
Effective Tax Rate	TBA

MPS Pharmaa Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	TBA	TBA	0.03
Operating Expenses Annual	0.80	0.95	0.71
Operating Profit Annual	-0.71	-0.92	-0.42
Interest Annual	0.00	0.00	0.00
Depreciation	0.15	0.15	0.51
Net Profit Annual	-0.83	-1.05	-0.14
Tax Annual	-0.02	-0.02	-0.79

Particulars	Mar 2024
Total Revenue Annual	TBA
Operating Expenses Annual	0.80
Operating Profit Annual	-0.71
Interest Annual	0.00
Depreciation	0.15
Net Profit Annual	-0.83
Tax Annual	-0.02

MPS Pharmaa Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.01	0.01	0.01
Cash Flow from Operations	-0.63	-0.87	-4.34
Cash Flow from Investing	0.12	-0.10	0.46
Cash Flow from Financing	0.51	0.96	3.88
Cash Flow at the End	0.01	0.01	0.01

Particulars	Mar 2024
Cash Flow at the Beginning	0.01
Cash Flow from Operations	-0.63
Cash Flow from Investing	0.12
Cash Flow from Financing	0.51
Cash Flow at the End	0.01

MPS Pharmaa Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	TBA	TBA	-1,400
PBIT Margin (%)	TBA	TBA	-3,100
PBT Margin (%)	TBA	TBA	-3,100
Net PROFIT Margin (%)	TBA	TBA	-466.67
Return On Networth / Equity (%)	TBA	TBA	TBA
Return On Networth /Employed (%)	TBA	TBA	TBA
Return On Assets (%)	TBA	TBA	TBA
Total Debt / Equity (X)	2.95	1.90	1.48
Asset Turnover Ratio (%)	TBA	TBA	TBA

Particulars	Mar 2024
PBDIT Margin (%)	TBA
PBIT Margin (%)	TBA
PBT Margin (%)	TBA
Net PROFIT Margin (%)	TBA
Return On Networth / Equity (%)	TBA
Return On Networth /Employed (%)	TBA
Return On Assets (%)	TBA
Total Debt / Equity (X)	2.95
Asset Turnover Ratio (%)	TBA

MPS Pharmaa Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	4.01	4.14	4.17
Total Current Assets Annual	2.12	2.10	2.03
Non Current Assets Annual	7.81	8.08	8.13
Total Shareholders Funds Annual	1.97	2.79	3.83
Total Assets Annual	9.94	10.19	10.16

Particulars	Mar 2024
Fixed Assets Annual	4.01
Total Current Assets Annual	2.12
Non Current Assets Annual	7.81
Total Shareholders Funds Annual	1.97
Total Assets Annual	9.94

MPS Pharmaa Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 23, 2024, MPS Pharmaa Ltd has a market capitalization of 6.13 Cr. Value Research classifies it as a Micro-Cap company.

No, MPS Pharmaa Ltd is not debt-free with a debt-to-equity ratio of 3.69.

In FY 2023 , MPS Pharmaa Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

MPS Pharmaa Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and -100.0% annually, respectively..

MPS Pharmaa Ltd's current PE ratio is -7.39.

MPS Pharmaa Ltd's ROCE averaged -10.0% from the FY ending March 2022 to 2024, with a median of -9.7%. It peaked at -9.2% in March 2024, reflecting strong capital efficiency over the period..

MPS Pharmaa Ltd's latest EBIT is Rs. -0.85 Cr, surpassing the average EBIT of Rs. -0.95 Cr over the 5 years..